Likewise, reducing NK-derived GM-CSF with si-RNA also nullified the protective effects of Smad3 knockout NK cell therapy on the recruitment of M1 macrophages, which was aligned with the changes of GM-CSF levels in the tumor tissue (Fig. 3C). The gene discussed is CSF2; the disease is neoplasm.